RK
Ravi Kumar Gubbala
About Ravi Kumar Gubbala
Data last updated:
Ravi Kumar Gubbala has 17 years in corporate governance. Holds Director role. Currently with 4 companies, including Matrix Formulations Private Limited and White Cross Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alekhya Power Private Limited U74900TG2015PTC100472 | Director | 29 Apr 2017 | 2015 | – | Active |
| Nextware Solutions Private Limited U72200TG2011PTC076731 | Director | 27 Sep 2011 | 2011 | – | Active |
| Matrix Formulations Private Limited U24232TG2010PTC071978 | Director | 31 Dec 2010 | 2010 | – | Active |
| White Cross Pharmaceuticals Private Limited U24233TG2009PTC062934 | Director | 03 Mar 2009 | 2009 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kumar Gubbala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kumar Gubbala
Ravi Kumar Gubbala has 17 years in corporate governance. Holds Director role. Currently with 4 companies, including Matrix Formulations Private Limited and White Cross Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Ravi Kumar Gubbala is associated with 4 companies as Director, including Alekhya Power Private Limited, Nextware Solutions Private Limited, Matrix Formulations Private Limited.
Ravi Kumar Gubbala has expertise in General Business.
Ravi Kumar Gubbala has 17 years in corporate governance.
Ravi Kumar Gubbala currently holds positions at 4 companies: Alekhya Power Private Limited, Nextware Solutions Private Limited, Matrix Formulations Private Limited, White Cross Pharmaceuticals Private Limited.